share_log

Barclays Maintains Overweight on Twist Bioscience, Lowers Price Target to $40

Moomoo 24/7 ·  Apr 10 15:25

Barclays analyst Luke Sergott maintains Twist Bioscience (NASDAQ:TWST) with a Overweight and lowers the price target from $45 to $40.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment